No Data
We're Hopeful That Stoke Therapeutics (NASDAQ:STOK) Will Use Its Cash Wisely
Skorpios Trust Sells $27.2 Million of Stoke Therapeutics Stock
Express News | Skorpios Trust Reports 16.9% Stake in Stoke Therapeutics as of Sept 19 Vs 23.4% as of April 17- SEC Filing
Form 144 | Stoke Therapeutics(STOK.US) Insider Proposes to Sell 29.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 19, $Stoke Therapeutics(STOK.US)$ Insider Blue Horizon E LTD intends to sell 1.94 million shares of its common stock on Sep 19, with a total market value of approximately $
TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy Rating
BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $29